Shanghai, China

Suzhen Dong

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Rudong Ruien Pharmaceutical Technology Co. Ltd. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Suzhen Dong. Retrieved from https://idiyas.com/inventor/suzhen-dong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Suzhen Dong in Antibacterial and Antitumor Research

Introduction

Suzhen Dong is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new antibacterial and antitumor agents. His innovative work focuses on spiro three-membered and five-membered ring peptide deformylase inhibitors.

Latest Patents

Suzhen Dong holds a patent for a spiro three-membered ring and spiro five-membered ring peptide deformylase inhibitor. This invention demonstrates antibacterial activity against antibiotic-resistant Gram-positive strains by inhibiting the peptide deformylase necessary for bacterial protein synthesis. Additionally, it shows promise in promoting apoptosis in various cancer cell strains, including colorectal cancer, leukemia, lung cancer, and breast cancer, among others. The patent highlights the selective action of these inhibitors, which do not interfere with human protein synthesis while effectively targeting bacterial cells.

Career Highlights

Throughout his career, Suzhen Dong has worked with reputable companies such as Rudong Ruien Pharmaceutical Technology Co. Ltd and Guangdong Hebo Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and research.

Collaborations

Suzhen Dong has collaborated with notable colleagues, including Wenhao Hu and Fengping Lv. These partnerships have likely enhanced his research capabilities and broadened the impact of his inventions.

Conclusion

Suzhen Dong's innovative work in developing peptide deformylase inhibitors represents a significant advancement in the fight against antibiotic resistance and cancer. His contributions to the pharmaceutical field continue to pave the way for new therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…